Login to Your Account

Mesoblast's MPC Cell Therapy Neofuse Heading to Phase III

By Nuala Moran
Staff Writer

Tuesday, January 15, 2013
Mesoblast Ltd. is preparing to discuss plans for Phase III development with regulators and weighing the partnering strategy after reporting positive Phase II results for its Neofuse cell therapy for treating degenerative disc disease by lumber spinal fusion.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription